KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 155 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $34 | -100.0% | 18,799 | -16.3% | 0.00% | -66.7% |
| Q3 2022 | $123,000 | -65.4% | 22,469 | -71.5% | 0.01% | -70.0% |
| Q2 2022 | $355,000 | -9.4% | 78,720 | +29.0% | 0.04% | -7.0% |
| Q4 2021 | $392,000 | -38.9% | 61,045 | +0.1% | 0.04% | -40.3% |
| Q1 2021 | $642,000 | +247.0% | 61,002 | +411.1% | 0.07% | +140.0% |
| Q4 2020 | $185,000 | -43.1% | 11,936 | -37.5% | 0.03% | -33.3% |
| Q3 2018 | $325,000 | +261.1% | 19,084 | +88.0% | 0.04% | +87.5% |
| Q1 2016 | $90,000 | – | 10,153 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,180,700 | $137,941,000 | 10.27% |
| Palo Alto Investors LP | 4,299,901 | $82,601,000 | 6.92% |
| Fairmount Funds Management LLC | 562,351 | $10,803,000 | 6.55% |
| Avoro Capital Advisors LLC | 7,000,000 | $134,470,000 | 4.54% |
| Pinz Capital Management, LP | 8,820 | $1,694,000 | 4.44% |
| Birchview Capital, LP | 148,000 | $2,843,000 | 2.52% |
| Elk Creek Partners, LLC | 699,951 | $13,446,000 | 2.31% |
| Parkman Healthcare Partners LLC | 215,802 | $4,146,000 | 1.92% |
| EAM Global Investors LLC | 136,402 | $2,620,000 | 1.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 550,000 | $10,566,000 | 1.32% |